Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Michala Varejckova"'
Autor:
Ivana Nemeckova, Agnieszka Serwadczak, Barbara Oujo, Katerina Jezkova, Jana Rathouska, Petra Fikrova, Michala Varejckova, Carmelo Bernabeu, Jose M Lopez-Novoa, Stefan Chlopicki, Petr Nachtigal
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119665 (2015)
Increased levels of a soluble form of endoglin (sEng) circulating in plasma have been detected in various pathological conditions related to cardiovascular system. High concentration of sEng was also proposed to contribute to the development of endot
Externí odkaz:
https://doaj.org/article/87c695d80bfc4061b3ae8f0a0b788af6
Autor:
Eva Dolezelova, Lenka Peslova, Alena Mrkvicova, Eunate Gallardo-Vara, Katerina Blazickova, Petra Fikrova, Jana Rathouska, Petr Nachtigal, Miguel Pericacho, Ivana Nemeckova, Michala Varejckova, Barbora Vitverova
Publikováno v:
Heart and Vessels. 32:1013-1024
A soluble form of endoglin (sEng) released into the circulation was suggested to be a direct inducer of endothelial dysfunction, inflammation and contributed to the development of hypertension by interfering with TGF-β signaling in cardiovascular pa
Autor:
Kristyna Tysonova, Jana Rathouska, Elzbieta Buczek, Michala Varejckova, Petr Nachtigal, Stefan Chlopicki, Carmelo Bernabeu, Barbora Vitverova, José M. López-Novoa, Petra Fikrova, Agnieszka Serwadczak, Eva Dolezelova, Ivana Nemeckova, K. Jezkova
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
14 p.-6 fig.
Aims: A soluble form of endoglin (sEng) was proposed to participate in the induction of endothelial dysfunction in small blood vessels. Here, we tested the hypothesis that high levels of sEng combined with a high-fat diet induce end
Aims: A soluble form of endoglin (sEng) was proposed to participate in the induction of endothelial dysfunction in small blood vessels. Here, we tested the hypothesis that high levels of sEng combined with a high-fat diet induce end
Autor:
Michala Varejckova, Zbynek Strasky, K. Jezkova, Ivana Nemeckova, Lenka Zemankova, Jana Rathouska, Petr Nachtigal
Publikováno v:
Heart and Vessels. 30:241-248
C57BL/6J (B6) mice were demonstrated to be the most susceptible and C3H/HeJ (C3H) mice the most resistant to development of atherosclerosis. We hypothesized, whether pro-atherogenic (P-selectin, VCAM-1, and ICAM-1) and anti-atherogenic (endoglin and
Autor:
Katerina Blazickova, Jana Rathouska, Petr Nachtigal, Michala Varejckova, Barbora Vitverova, Stanislav Micuda, Petra Fikrova, Alena Prasnicka, Ivana Nemeckova, Eva Dolezelova, Carmelo Bernabeu, M. Vicen, Eunate Gallardo-Vara
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
34 p.-7 fig.
Aims: Endoglin is a transmembrane glycoprotein, that plays an important role in regulating endothelium. Proteolytic cleavage of membrane endoglin releases soluble endoglin (sEng), whose increased plasma levels have been detected in
Aims: Endoglin is a transmembrane glycoprotein, that plays an important role in regulating endothelium. Proteolytic cleavage of membrane endoglin releases soluble endoglin (sEng), whose increased plasma levels have been detected in
Publikováno v:
Atherosclerosis. 275:e106
Autor:
Jana, Rathouska, Katerina, Jezkova, Ivana, Nemeckova, Lennka, Zemankova, Michala, Varejckova, Petr, Nachtigal
Publikováno v:
Histology and histopathology. 30(2)
Endoglin (TGF-β receptor III), has been demonstrated to affect vascular endothelium and atherosclerosis. Moreover, it was also demonstrated that endoglin is involved in inflammation and plays a role in leukocyte adhesion and transmigration in vitro
Autor:
Eva Dolezelova, Ivana Nemeckova, Petra Fikrova, Michala Varejckova, Barbora Vitverova, Petr Nachtigal
Publikováno v:
Atherosclerosis. 252:e156
Autor:
K. Jezkova, Jana Rathouska, Michala Varejckova, Petr Nachtigal, Ivana Nemeckova, Barbora Vitverova, Carmelo Bernabeu, Petra Fikrova, Eva Dolezelova, Stefan Chlopicki, J.M. Novoa
Publikováno v:
Atherosclerosis. 252:e160
Autor:
Barbara Oujo, Michala Varejckova, José M. López-Novoa, Ivana Nemeckova, Carmelo Bernabeu, Stefan Chlopicki, K. Jezkova, Jana Rathouska, Agnieszka Serwadczak, Petr Nachtigal, Petra Fikrova
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS ONE, Vol 10, Iss 3, p e0119665 (2015)
PLoS ONE
instname
PLoS ONE, Vol 10, Iss 3, p e0119665 (2015)
PLoS ONE
Petr Nachtigal et alt. 13 p.-7 fig.
Increased levels of a soluble form of endoglin (sEng) circulating in plasma have been detected in various pathological conditions related to cardiovascular system. High concentration of sEng was also proposed
Increased levels of a soluble form of endoglin (sEng) circulating in plasma have been detected in various pathological conditions related to cardiovascular system. High concentration of sEng was also proposed